Toward functional precision oncology: organotypic brain slices in glioblastoma
Frontiers in Oncology · 21.08.2026 · 16
DOI: 10.3389/fonc.2026.1845730 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 21.08.2026. Verfasst von Aleksandra Bondar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Technical University of Munich (TUM) School of Medicine and Health, Technical University of Munich (TUM) University…. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Glioblastoma remains the most aggressive primary brain tumor in adults and is characterized by extensive invasiveness, high recurrence rates, and pronounced inter- and intratumoral heterogeneity. These features continue to limit the effectiveness of current therapies and highlight the need for experimental models that more faithfully capture the complexity of the disease. Conventional two-dimensional in vitro systems, while highly accessible and experimentally tractable, fail to reproduce the three-dimensional architecture, extracellular matrix organization, and dynamic tumor–microenvironment interactions that critically shape glioblastoma behavior. Although three-dimensional spheroid and organoid models partially address these limitations, they still incompletely reflect the structural and cellular complexity of native brain tissue. Organotypic brain tissue slice cultures have emerged as a powerful intermediate model that preserves native cytoarchitecture, cellular diversity, and key aspects of the tumor microenvironment. In this review, we provide an integrated overview of organotypic slice models derived from mouse, rat, and human tissue, with a focus on their application in studying glioblastoma invasion, tumor–microenvironment interactions, and therapeutic response. We discuss methodological approaches, advances in tissue preservation and bioengineering, and the integration of molecular and electrophysiological readouts. Particular emphasis is placed on human brain slice cultures, which retain patient-specific structural and cellular features and therefore offer a unique platform for investigating tumor heterogeneity and individualized treatment responses. At the same time, we address current limitations, including restricted viability, methodological variability, and the need for standardized experimental frameworks. By positioning organotypic brain slices as structurally preserved tumor ecosystems rather than simplified experimental systems, this review highlights their potential to bridge mechanistic discovery and translational application, and to contribute to the development of functionally informed precision oncology strategies in glioblastoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Technical University of Munich (TUM) School of Medicine and Health, Technical University of Munich (TUM) University Hospital, Technical University of Munich, Munich, Germany.
- Department of Anaesthesia, Technical University of Munich (TUM) School of Medicine and Health, Technical University of Munich (TUM) University Hospital, Technical University of Munich, Munich, Germany.
Zitieren
APA
Bondar, A., Raulefs, S., Wrana, J., Ballmann, M., Rammes, G., Combs, S. E., & Schmid, T. E. (2026). Toward functional precision oncology: organotypic brain slices in glioblastoma. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1845730
Vancouver
Bondar A, Raulefs S, Wrana J, Ballmann M, Rammes G, Combs SE, et al. Toward functional precision oncology: organotypic brain slices in glioblastoma. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1845730
BibTeX
@article{Bondar2026,
author = {Bondar, Aleksandra and Raulefs, Susanne and Wrana, Jette and Ballmann, Markus and Rammes, Gerhard and Combs, Stephanie E and Schmid, Thomas Ernst},
title = {Toward functional precision oncology: organotypic brain slices in glioblastoma},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1845730}
}
EUVIMED